scispace - formally typeset
M

Mangalakumari Jeyanathan

Researcher at McMaster University

Publications -  53
Citations -  3103

Mangalakumari Jeyanathan is an academic researcher from McMaster University. The author has contributed to research in topics: Immunity & Tuberculosis vaccines. The author has an hindex of 23, co-authored 43 publications receiving 2208 citations. Previous affiliations of Mangalakumari Jeyanathan include University College London.

Papers
More filters
Journal ArticleDOI

Immunological considerations for COVID-19 vaccine strategies.

TL;DR: The immunological principles that need to be taken into consideration in the development of COVID-19 vaccine strategies are discussed and their strengths and potential shortfalls are examined, and inferences about their chances of success are made.
Journal ArticleDOI

Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection.

TL;DR: Findings contradict the dominant view that latent organisms exist in old classic tuberculous lesions, and have important implications for strategies aimed at the elimination of latent and persistent bacilli.
Journal ArticleDOI

Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and Is Critical to Trained Immunity.

TL;DR: It is shown that respiratory viral infection induces long-lasting memory alveolar macrophages, which are programed to express high MHC II, a defense-ready gene signature, and increased glycolytic metabolism, and produce, upon re-stimulation, neutrophil chemokines.
Journal ArticleDOI

A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity

TL;DR: Although AdHu5Ag85A was immunogenic in both trial volunteer groups, it much more potently boosted polyfunctional CD4+ and CD8+ T cell immunity in previously BCG-vaccinated volunteers, suggesting that, at least for certain antigens, adenovirally delivered boosts can enhance the immune response to TB.